IVF Devices Market Overview
The global IVF Devices market was calculated at USD 3.05 billion in 2021 and projected to reach USD 9.22 billion by 2028, growing at a CAGR of 17.2% during the forecast period, 2022-2028. Growing reprotourism and increased infertility in men and women. Infertility is one of the biggest health problems facing people around the world. In vitro fertilization is one of the most widely used treatments for the problem of infertility. Increased infertility, increased awareness of IVF, increased demand for advanced IVF technology, and increased IVF success rate are the factors that drive the growth of the IVF devices market globally.
Furthermore, in vitro fertilization provides patients with freezing eggs early. Which later can be devised by using in vitro fertilization. In vitro fertilization, a technical process that minimizes the risk, is the factor that drives the global in-vitro fertilization market.
What is In-Vitro Fertilization (IVF) Device?
In-Vitro Fertilization (IVF) is an innovative clinical technique that includes a mixture of surgical processes and drugs to assist the implantation of eggs within the uterus. This technique is largely finished at the ladies that can’t have a normal pregnancy. In this technique, eggs are infused with sperm out of doors the uterus in a synthetic environment. This technique is likewise known as insemination, in which sperms and eggs are saved in a unique field to sell the fertilization of eggs. After some days, the fertilized egg is implanted into the womb of ladies, which is known as embryo transfer.
Growth Driver
Increasing demand for in-vitro fertilization
Increasing male and female infertility rates in some developing and developed countries has increased the demand for in vitro fertilization (IVF) procedures. IVF is becoming more important among fertile couples who suffer from genetic disorders and do not want to be passed on to their offspring in various developed countries. Recent advances in IVF equipment and reagents are also good signs for the market. The tendency to delay pregnancy is generally increasing worldwide and is driving the in vitro fertilization (IVF) equipment market over the forecast period.
Opportunity
Growing technological developments
Growing technological development and an increase in medical tourism in some developing countries are significant growth opportunities for the in-vitro fertilization devices market due to the current advances that can extend the usage of in-vitro fertilization devices to a huge phase of society with and without an infertility diagnosis. For instance, Vitrification, a flash or fast-freeze technology, has substantially stepped forward from cryopreserved embryos. Patients’ usage of frozen embryos has fulfilments quotes the same too, or higher than those from fresh embryo switch cycles, are providing growth opportunities for the in-vitro fertilization devices market.
Restraints
low awareness of IVF
Low awareness among the peoples of in vitro fertilization services, complications related to in vitro fertilization treatment, higher costs of IVF devices, ethical issues, some countries, the use of in vitro fertilization treatment is banned or regulated, are the key factors among others are restraining the growth of the in vitro fertilization devices market.
Pre-Covid-19 impact on global IVF Devices market
In the Pre-covid-19 period, the in vitro fertilization device market is growing due to the growing usage of in vitro fertilization devices in various end-users such as hospitals, fertility clinics, surgical centres and others. Upsurge in the number of same-sex marriages, increase in healthcare spending worldwide, the surge in the number of gamete donations, the growing infertility rate and increase in disposable income significantly contribute to the growth of the in vitro fertilization device market.
Covid-19 impact on global IVF Devices market
The outbreak of Covid-19 is likely to negatively impact the growth of the global in-vitro fertilization device market. The Covid-19 pandemic is straining healthcare systems around the world. Due to the rise in the incidence of Covid-19 cases, non-essential surgical procedures, such as in vitro fertilization, cases, embryo transfer procedures, whether fresh or frozen, interrupted elective surgery, and non-urgent diagnostic procedures. Therefore, the ongoing blockade of fertility treatment has slowed the growth of the in vitro fertilization market during the covid pandemic.
Post Covid-19 impact on global IVF Devices market
After the covid-19 pandemic, increasing demand for in vitro fertilization devices in end users and advancement in technology. The availability of funding and a rise in research activities to expand the culture media The use of disposable slides for counting sperm, image-based tracking systems for separating the best motile sperm, and disposable microchips are some of the innovations which is the factor in the growth of the IVF Devices market in post covid period.
Product Type Segmental Analysis
Based on the product type segmental analysis, the global in-vitro fertilization (IVF) devices market is segregated into an instrument, accessory & disposable, and reagent and media. The accessory & disposable segment is estimated to have the maximum market share in the product type for the IVF Devices market Due to rising demand for advanced IVF devices. In addition, market players are introducing disposable products such as slides, needles and chambers to meet needles, sterility and regulatory requirements.
Technology Segmental Analysis
Based on the technology, the global in-vitro fertilization (IVF) devices market is segregated into donor egg IVF, fresh embryo IVF, and frozen embryo IVF. The new embryo IVF segment is projected to have the largest market share for the IVF Devices market, increasing the fresh embryo IVF adoption due to the larger success rate and increasing infertility rate. Using fresh embryos rather than frozen in-vitro fertilization from fresh donor eggs improves in-vitro fertilization birth rates, increasing demand for easy-to-use equipment.
End-User Segmental Analysis
Based on the end-user segmental analysis, the global in-vitro fertilization (IVF) devices market is categorized into fertility clinics, surgical centers, hospitals, and clinical research institutes. The fertility clinic segment is anticipated to have the largest market share in the in vitro fertilization Devices market. Due to cost-effective treatment availability of specialists, minimal or no chances of Hospital-Acquired Infections, and the rising in various fertility clinics. Furthermore, the Surgical Centres segment is anticipated to rise significantly as the numeral of surgical centers increases in developing regions and increases usage of in vitro fertilization (IVF) in surgical centers.
Region Segmental Analysis
The in-vitro fertilization (IVF) devices market is categorized as North America, Asia Pacific, Europe, South America, and the Middle East & Africa based on the region. The Asia Pacific region is expected to considerably growth during 2022-2028. Due to the growing awareness of in-vitro fertilization treatment, the rising number of infertile populations increased disposable income, and cost-effective in-vitro fertilization treatment is the factor in boosting the in-vitro fertilization market in the Asia Pacific region.
Competitor Analysis
Companies include Thermo Fisher Scientific Inc., Cook Medical Inc., Progyny Inc., Vitrolife AB, LAF Technologies, ESCO Micro, Inter Medics, Ovascience Inc., Rocket Medical, Merck Inc., Genea Limited, Cooper Surgical, EMD Serono Inc., Others prominent players are the key players in the global in-vitro fertilization (IVF) devices market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global IVF Devices market manufacturing firm
- Local Governments
- Regulatory bodies
- Suppliers
- Retailers
Recent Development
- In 2022, Cook Medical announced that it would acquire the Cook Medical Reproductive Health business from The Cooper Companies, Inc.
- In 2021, EMD Serono Launched New Fertility LifeLines™ Portal to Surge Support and Access for Patients Impacted by Infertility.
- In 2021, Merck Inc. announced the acquisition of Acceleron Pharma Inc.
- In 2018, Vitrolife AB received EmbryoScope regulatory approval in China, a time-lapse system used in assisted reproductive technology for undisturbed culture and improved embryo selection.
Scope of the Report
| Report Attribute |
Details |
| Market Size Value in 2021 |
USD 3.05 Billion |
| The revenue forecast in 2028 |
USD 9.22 Billion |
| Growth Rate |
CAGR of 17.2% from 2022 to 2028 |
| Historical data |
2017 – 2020 |
| Base Year |
2021 |
| Forecast period |
2022 – 2028 |
| Region covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled |
Thermo Fisher Scientific Inc., Cook Medical Inc., Progyny Inc., Vitrolife AB,
LAF Technologies, ESCO Micro, Inter Medics, Ovascience Inc., Rocket Medical,
Merck Inc., Genea Limited, Cooper Surgical, EMD Serono Inc. |
Market Modelling
By Product type
- Instrument
- Sperm Separation System
- Cryosystems
- Incubators
- Ovum Aspiration Pumps
- Cabinets
- Micromanipulators
- Others
- Accessory & Disposable
- Reagent and Media
- Semen Processing Media
- Cryopreservation Media
- Ovum Processing Media
- Embryo Culture Media
By Technology
- Donor Egg IVF
- Fresh Embryo IVF
- Frozen Embryo IVF
By End-User
- Hospital
- Fertility Clinic
- Surgical Center
- Clinical Research Institute
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Baby Powder Market
Smart Factory Market
Flexible Space Market
Produced Water Treatment Market
Metal Nanoparticles Market
Outdoor Camping Equipment Market
Online Sports Retailing Market
Thermal Storage Market
Global Rotary Compressor Excel Data